The oncologic effect of a gonadotropin releasing hormone (GnRH) agonist for ovarian protection during breast cancer chemotherapy

被引：0
|
作者：
Kim, H. J.
Lee, M. H.
Lee, J. E.
Park, S. H.
Lee, E. S.
Kang, Y-J
Lee, J. H.
Shin, H. N.
Kim, S. I.
Im, S. A.
Ahn, S. H.
Lee, K. S.
Sohn, J.
Han, W.
Nam, S. J.
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Div Breast & Endocrine, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Breast & Endocrine Surg, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Natl Canc Ctr, Res Inst Natl Canc Control & Evaluat, Res Inst & Hosp, Canc Biostat Branch, Goyang, South Korea
[6] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Chang Won, South Korea
[7] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea
[8] Yonsei Univ, Coll Med, Div Med Oncol, Seoul 120749, South Korea
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P1-12-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-12-09
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Gonadotropin-releasing hormone (GNRH) agonist therapy and fracture risk in men with prostate cancer
    Smith, MR
    Boyce, SP
    Moyneur, E
    Duh, MS
    Raut, M
    Brachnan, J
    Sung, JC
    Mallett, D
    JOURNAL OF UROLOGY, 2005, 173 (04): : 74 - 74
  • [42] GnRH agonist for gonadal protection during chemotherapy
    Falcone, Tommaso
    Moore, Halle C. F.
    HUMAN REPRODUCTION, 2015, 30 (12) : 2711 - 2712
  • [43] GONADOTROPIN AND OVARIAN-STEROID PRODUCTION IN POLYCYSTIC OVARIAN SYNDROME DURING SUPPRESSION WITH A GONADOTROPIN-RELEASING HORMONE AGONIST
    TANBO, T
    ABYHOLM, T
    MAGNUS, O
    HENRIKSEN, T
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1989, 28 (03) : 147 - 151
  • [44] Gonadotropin-Releasing Hormone Agonists for the Preservation of Ovarian Function During Chemotherapy
    Tomao, Federica
    Panici, Pierluigi Benedetti
    Tomao, Silverio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3310 - 3311
  • [45] OVARIAN GONADOTROPIN-RELEASING HORMONE (GNRH) RECEPTORS - CHARACTERIZATION, DISTRIBUTION, AND INDUCTION BY GNRH
    PIEPER, DR
    RICHARDS, JS
    MARSHALL, JC
    ENDOCRINOLOGY, 1981, 108 (04) : 1148 - 1155
  • [46] Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?
    Del Mastro, Lucia
    Lambertini, Matteo
    ONCOLOGIST, 2015, 20 (11): : 1233 - 1235
  • [47] Pregnancy Rate and Preservation of Cyclic Ovarian FunctionWith Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy Reply
    Demeestere, Isabelle
    Turan, Volkan
    Oktay, Kutluk
    JAMA ONCOLOGY, 2016, 2 (04) : 546 - 547
  • [48] Design of mimetics of gonadotropin releasing hormone (GnRH) with effects on proliferation of breast cancer cells
    Moore, GJ
    Pires, JM
    Hayden, LJ
    PROCEEDINGS OF THE FORTY-SECOND ANNUAL MEETING OF THE WESTERN PHARMACOLOGY SOCIETY, 1999, 42 : 87 - 90
  • [49] Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist
    Olivennes, F
    Fanchin, R
    Bouchard, P
    Taieb, J
    Frydman, R
    FERTILITY AND STERILITY, 1996, 66 (01) : 151 - 153
  • [50] CLINICAL PROFILES OF PREMENOPAUSAL BREAST CANCER PATIENTS DURING TAMOXIFEN TREATMENT AFTER ADJUVANT CHEMOTHERAPY WITH GnRH AGONIST FOR OVARIAN PROTECTION.
    Kim, N. Y.
    Lee, D. -Y.
    Kim, M. J.
    Choi, D.
    FERTILITY AND STERILITY, 2010, 94 (04) : S190 - S190
12345